Skip to content

Oto Smartphone App in Treating Tinnitus Amongst Adult Patients Compared with Standard Talking Therapies

Multimodality Smartphone App Delivered Therapy for Tinnitus - a Protocol for a Randomised Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06623123
Enrollment
160
Registered
2024-10-02
Start date
2024-06-20
Completion date
2025-06-20
Last updated
2024-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Keywords

tinnitus, therapeutics, telemedicine, outcomes, otology, otolaryngology

Brief summary

A study that looks at treating tinnitus and its associated burden, insomnia and quality of life effects with a smartphone app when compared with the talking therapies already offered on the national health service. Three separate questionnaires will be used to collect this data from patients at regular time intervals.

Detailed description

Single-site randomised controlled study looking at tinnitus burden, insomnia severity and quality of life in adults with chronic primary subjective tinnitus when using Oto smartphone app compared with National Institute for Health and Care Excellence (NICE) approved tinnitus retraining therapy. This will be assessed objectively through questionnaires at the baseline meeting, one month, three months and six months.

Interventions

DEVICEOto Smartphone Application (Oto Health Ltd)

The smartphone application delivers personalized tinnitus therapy combining evidence-based CBT with mindfulness, patient education as well as physical therapy such as stretches and exercises. There are additional sounds available to listen to from the sound library. There will be a structured programme that the participants can work through however they are encouraged to personalise their own therapy.

Tinnitus-retraining therapy will be offered in the control arm which represents the standard evidence-based intervention on the NHS. (2) Participants enrolled to this arm will undertake tinnitus retraining therapy with a trained audiologist. The sessions will last 30 minutes with the option for further sessions should the patient which to have more support with their tinnitus to mimic the NHS programme as much as possible. These sessions will encompass a brief audiological history followed by therapy tailored to the patient's needs allowing for patient-centred optimisation of tinnitus burden and secondary comorbidities. This may include relaxation, CBT and advice surrounding sound as well as white noise masking therapy.

Sponsors

East and North Hertfordshire NHS Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

researchers to data generated

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients (male or female) aged over 18 years of age presenting to NHS ENT and hearing services with primary non-pulsatile tinnitus irrespective of hearing. * Patients must be suffering from tinnitus for a minimum of 3 months * Patients that have a willingness to use as well as have access to a smartphone device capable of running Oto. * Willing and able to provide written informed consent. * Those that would be offered tinnitus retraining therapy (TRT) as management for their primary tinnitus

Exclusion criteria

* Patients with secondary tinnitus as confirmed by magnetic resonance imaging (MRI). * Patients undergoing any other tinnitus therapies concurrently (including hearing aids / implants). Previous tinnitus therapies including CBT in the past are accepted. * Patients who are not willing to use the app due to not having a suitable phone to download the application or due to own limitations in working Oto.

Design outcomes

Primary

MeasureTime frameDescription
Tinnitus Burden6 months total post intervention start dateTinnitus burden via Tinnitus Functional Index questionnaires at 0 months (T0), 1 month (T1), 3 months (T2) and 6 months (T3).

Secondary

MeasureTime frameDescription
Insomnia Severity6 months total post intervention start dateInsomnia index as calculated via Insomnia Severity Index questionnaire at 0 months (T0), 1 month (T1), 3 months (T2) and 6 months (T3).
Quality of Life6 months total post intervention start dateQuality of life as calculated via the WHO Quality of Life - BREF questionnaire at 0 months (T0), 1 month (T1), 3 months (T2) and 6 months (T3).

Countries

United Kingdom

Contacts

Primary ContactAmir Habeeb, MBBS BSc MSc MRCS (ENT) AFHEA
amir.habeeb1@nhs.net+447850592603

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026